A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
Nutriband secures US patent for abuse deterrent patch
ORLANDO - Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products with a market capitalization of $74 million, announced Monday that it has received a Notice of ...
BioSpace7d
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Pharm Exec10d
The Regulatory Response to Abuse-Deterrent Drugs
Paul Howe, chief commercial officer at Protega Pharma, discusses how regulatory agencies are updating their policies based on the presence of abuse-deterrent medications.
Pharm Exec14d
Using Digital Therapeutics with Abuse-Deterrent Pain Medication
Pharmaceutical Executive: How important is the need for abuse-deterrent immediate-release opioids? Paul Howe: This is a societal need that we have. We have an opportunity to really do something ...
pharmaphorum17d
Pain Therapeutics' opioid drug fails to gain FDA approval
The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. In a dreaded complete response letter, the FDA said the benefits listed in the ...
FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversaâ„¢
The expected issuance of this patent further expands Nutriband’s intellectual property protection in the United States for its portfolio of abuse deterrent transdermal products based on its ...
OKC Thunder Wire6d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
Yahoo Finance9d
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
which recently won approval for an abuse-deterrent opioid. The opportunity for drugmakers to develop better pain management alternatives is there — 80 million people are prescribed medication to ...
pharmaphorum26d
Pain Therapeutics' opioid drug fails to gain FDA approval
The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time. In a dreaded complete response letter, the FDA said the benefits listed in the ...